Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „Lutetium (177Lu) chloride Billev (previously Illuzyce)“
Suchtreffer
Begriffe & Kennungen
Lutetium (177Lu) chloride Billev (previously Illuzyce)
Eintrag öffnenLutetium (177Lu) chloride Billev (previously Illuzyce) · 4.1 Therapeutic indications · 1
Eintrag öffnenLutetium (177Lu) chloride Billev (previously Illuzyce) · 4.3 Contraindications · 1
Eintrag öffnenLutetium (177Lu) chloride Billev (previously Illuzyce) · 4.3 · For information on contraindications to particular lutetium (177Lu)-labelled medicinal products prepared by ra
Eintrag öffnenLutetium (177Lu) chloride Billev (previously Illuzyce) · 4.3 · • Hypersensitivity to the active substance or to any of the excipients listed in section 6.1. • Established or
Eintrag öffnenLutetium (177Lu) chloride Billev (previously Illuzyce) · 4.4 Special warnings and precautions for use · 1
Eintrag öffnenLutetium (177Lu) chloride Billev (previously Illuzyce) · 4.5 Interaction with other medicinal products and other forms of interaction · 1
Eintrag öffnenLutetium (177Lu) chloride Billev (previously Illuzyce) · 4.5 · For information concerning interactions associated with the use of lutetium (177Lu)-labelled medicinal product
Eintrag öffnenLutetium (177Lu) chloride Billev (previously Illuzyce) · 4.5 · No interaction studies of lutetium (177Lu) chloride with other medicinal products have been performed.
Eintrag öffnenLutetium (177Lu) chloride Billev (previously Illuzyce) · 4.6 Fertility, pregnancy and lactation · 1
Eintrag öffnenLutetium (177Lu) chloride Billev (previously Illuzyce) · 4.8 Undesirable effects · 1
Eintrag öffnenLutetium (177Lu) chloride Billev (previously Illuzyce) · 4.8 · 6 Description of selected adverse reactions
Eintrag öffnenLutetium (177Lu) chloride Billev (previously Illuzyce) · 4.8 · Adverse reactions are divided into groups according to the MedDRA convention frequencies: Very common (≥ 1/10)
Eintrag öffnenLutetium (177Lu) chloride Billev (previously Illuzyce) · 4.8 · Adverse reactions following the administration of a lutetium (177Lu)-labelled medicinal product prepared by ra
Eintrag öffnenLutetium (177Lu) chloride Billev (previously Illuzyce) · 4.8 · Alopecia Alopecia, described as mild and temporary, has been observed among patients receiving lutetium (177Lu
Eintrag öffnenLutetium (177Lu) chloride Billev (previously Illuzyce) · 4.8 · Dry mouth Dry mouth has been reported among patients with metastatic castration resistant prostate cancer rece
Eintrag öffnenLutetium (177Lu) chloride Billev (previously Illuzyce) · 4.8 · Exposure to ionising radiation is linked with cancer induction and a potential for development of hereditary d
Eintrag öffnenLutetium (177Lu) chloride Billev (previously Illuzyce) · 4.8 · MedDRA system Very common Common Uncommon Not known organ class Neoplasms Refractory Acute myeloid benign, cyt
Eintrag öffnenLutetium (177Lu) chloride Billev (previously Illuzyce) · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenLutetium (177Lu) chloride Billev (previously Illuzyce) · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnen